年末交易与并购活动提振业绩表现
Deals and an M&A strengthen end-of-year numbers
生物技术与制药领域的最新动态
Deals and an M&A strengthen end-of-year numbers
Enhertu combo cleared for use in frontline breast cancer
Thrivent Financial for Lutherans Trims Holdings in Agilent Technologies, Inc. $A - MarketBeat
Thermo Fisher Scientific Inc. $TMO Shares Sold by Thrivent Financial for Lutherans - MarketBeat
Agilent Technologies (NYSE:A) Seems To Use Debt Quite Sensibly - Yahoo Finance
Most researchers would receive more recognition if assessed by article-level metrics than by journal-level metrics
Biased sampling driven by bacterial population structure confounds machine learning prediction of antimicrobial resistance
The Drosophila escape motor circuit shows differential vulnerability to aging linked to functional decay
CRISPR/Cas9 Endogenous Tagging in Drug Discovery
Agilent to Present at the 44th Annual J.P. Morgan Healthcare Conference - Business Wire
Agilent to Present at the 44th Annual J.P. Morgan Healthcare Conference - Barchart.com
Agilent (NYSE: A) schedules Jan. 13 J.P. Morgan Healthcare Conference presentation - Stock Titan
Chronic pain biotech Ambros Therapeutics emerges with $125M and Vivek Ramaswamy on board
‘Zombie’ biotech buyer Xoma to acquire Generation Bio
Aeovian gets $55M for tuberous sclerosis complex, to explore prospects in obesity
5 CDER directors in one year? Turnover threatens ‘institutional memory’ at US health agencies.
Onco3r Therapeutics divulges new TP53 stabilizers
Hangzhou Baicreat Pharma-Tech describes new PTPN1 and PTPN2 inhibitors
Aurora kinase B inhibitors disclosed in Nippon Shinyaku patent
Chinese scientists discover new C5aR antagonists